.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Farmers Insurance
Cipla
Fish and Richardson
Citi
QuintilesIMS
Boehringer Ingelheim
McKinsey
Teva
US Army

Generated: December 15, 2017

DrugPatentWatch Database Preview

Leo Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for LEO PHARM, and when can generic versions of LEO PHARM drugs launch?

LEO PHARM has nine approved drugs.

There are three US patents protecting LEO PHARM drugs.

There are one hundred and three patent family members on LEO PHARM drugs in thirty-four countries.

Summary for Leo Pharm

International Patents:103
US Patents:3
Tradenames:6
Ingredients:6
NDAs:9
Drug Master File Entries: 2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Leo Pharma AsTACLONEXbetamethasone dipropionate; calcipotriene hydrateSUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Leo Pharma AsPROTOPICtacrolimusOINTMENT;TOPICAL050777-002Dec 8, 2000ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Leo Pharma AsINNOHEPtinzaparin sodiumINJECTABLE;INJECTION020484-001Jul 14, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Leo PharmPINDACpinacidilCAPSULE, EXTENDED RELEASE;ORAL019456-001Dec 28, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Leo Pharma AsTACLONEXbetamethasone dipropionate; calcipotriene hydrateSUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Leo Pharma AsPROTOPICtacrolimusOINTMENT;TOPICAL050777-001Dec 8, 2000ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Leo Pharma AsTACLONEXbetamethasone dipropionate; calcipotriene hydrateOINTMENT;TOPICAL021852-001Jan 9, 2006ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Leo Pharma AsTACLONEXbetamethasone dipropionate; calcipotriene hydrateSUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Leo Pharma AsDOVONEXcalcipotrieneCREAM;TOPICAL020554-001Jul 22, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Leo PharmDOVONEXcalcipotrieneSOLUTION;TOPICAL020611-001Mar 3, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Leo Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharma AsDOVONEXcalcipotrieneOINTMENT;TOPICAL020273-001Dec 29, 1993► Subscribe► Subscribe
Leo Pharma AsTACLONEXbetamethasone dipropionate; calcipotriene hydrateSUSPENSION;TOPICAL022185-001May 9, 2008► Subscribe► Subscribe
Leo Pharma AsTACLONEXbetamethasone dipropionate; calcipotriene hydrateOINTMENT;TOPICAL021852-001Jan 9, 2006► Subscribe► Subscribe
Leo PharmDOVONEXcalcipotrieneSOLUTION;TOPICAL020611-001Mar 3, 1997► Subscribe► Subscribe
Leo Pharma AsPROTOPICtacrolimusOINTMENT;TOPICAL050777-001Dec 8, 2000► Subscribe► Subscribe
Leo Pharma AsTACLONEXbetamethasone dipropionate; calcipotriene hydrateOINTMENT;TOPICAL021852-001Jan 9, 2006► Subscribe► Subscribe
Leo Pharma AsPROTOPICtacrolimusOINTMENT;TOPICAL050777-001Dec 8, 2000► Subscribe► Subscribe
Leo Pharma AsDOVONEXcalcipotrieneCREAM;TOPICAL020554-001Jul 22, 1996► Subscribe► Subscribe
Leo Pharma AsDOVONEXcalcipotrieneCREAM;TOPICAL020554-001Jul 22, 1996► Subscribe► Subscribe
Leo Pharma AsPROTOPICtacrolimusOINTMENT;TOPICAL050777-002Dec 8, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for LEO PHARM drugs

Drugname Dosage Strength Tradename Submissiondate
tacrolimusOintment0.03%PROTOPIC11/22/2010
tacrolimusOintment0.1%PROTOPIC9/9/2010
calcipotriene and betamethasone dipropionateOintment0.005%/0.064%TACLONEX3/31/2010
calcipotrieneTopical Solution0.01%DOVONEX5/19/2006

Non-Orange Book Patents for Leo Pharm

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,566,286Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Leo Pharm Drugs

Country Document Number Estimated Expiration
Slovakia287653► Subscribe
Russian Federation2238734► Subscribe
Russian Federation2013100996► Subscribe
European Patent Office2859886► Subscribe
Japan2013075923► Subscribe
Australia774600► Subscribe
Japan2015155451► Subscribe
Japan5699169► Subscribe
Hungary0200879► Subscribe
MexicoPA01010676► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Chubb
McKesson
US Army
US Department of Justice
Mallinckrodt
Novartis
Healthtrust
Chinese Patent Office
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot